David R. Bauer
Lawyers
Filters
Intercept Pharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Trimble $800 million notes offering
The 6.1% notes are due 2033
Revolution Medicines $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Stanley Black & Decker $750 million notes offering
The investment-grade notes are due 2026 and 2028
European Biotech Acquisition $220 million combination with Oculis
We advised European Biotech Acquisition on its de-SPAC transaction
Ankura Consulting Group acquisition of Chartwell Compliance
We advised Ankura Consulting Group on the transaction
Arrow Electronics $500 million senior notes offering
The 6.125% investment-grade senior notes are due 2026
Eli Lilly $4 billion notes offering
The investment-grade notes are due 2026, 2033, 2053 and 2063
Intel $11 billion senior notes offering
The investment-grade offering comprises seven tranches of notes
CureVac $250 million follow-on offering
We advised CureVac on the equity offering